Disclaimer: Information presented on this site is a guide only. It may not necessarily be correct and is not intended to be taken as financial advice nor has it been prepared with regard to the individual investment needs and objectives or financial situation of any particular person. Stock quotes are believed to be accurate and correctly dated, but www.intradaystocktips.org does not warrant or guarantee their accuracy or date.
www.intradaystocktips.org takes no responsibility for any investment decisions based on recommendations provided on website.
Financial contents like Technical charts, historical charts and quotes are taken from NSE and Yahoo sites.
Note - All quotes are delayed by 15 minutes.
Google Adsense Ads are posted on every page of the website so visitors clicking on Ads and going to those links and carrying any financial deal is not at all related to www.intradaystocktips.org and any financial deal should be done on their own sole responsibility.
Please read at www.intradaystocktips.org/disclaimer.php before using any material or advice given at www.intradaystocktips.org
Free tips for Intraday Trading and today markets level
Page updates at 9:00 AM.
Market opens at 9:15 AM
Your Trading Place..
Stocks to watch today for trading
24 Nov 2015
How Market is going to move today?
Indian markets are expected to open lower tracking weak Asian markets.
Tomorrow is holiday for markets on account of Guru Nanak Jayanti.
Pfizer Ltd: The biggest deal in the history of pharmaceutical is here and Pfizer Inc. will become Pfizer plc. On Monday pharma giant Pfizer announced it has struck a deal with Irish drug maker Allergan for roughly $160 billion as part of a merger that would create one of the largest pharma company.
Gammon India Ltd: Bankers led by ICICI Bank have decided to initiate Strategic Debt Restructuring for Gammon India-wherein lenders would acquire controlling stake of 51% equity stake in the construction and engineering company.
Max India Ltd: The company plans to sell 23 per cent stake in Max Bupa Health Insurance to its UK-headquartered parent Bupa for Rs 191 crore in an all-cash transaction that values the health insurer at Rs 830 crore.
Wockhardt Ltd: India's drug pricing watchdog National Pharmaceutical Pricing Authority (NPPA) has exempted drug maker Wockhardt's three insulin products from price controls for five years, starting January 8, 2015.